Acarix AB

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0009268717
SEK
0.26
0.03 (11.65%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Acarix AB
AroCell AB
Corline Biomedical AB
SciBase Holding AB
Redsense Medical AB
Dignitana AB
Clinical Laserthermia Systems AB
Glycorex Transplantation AB
Episurf Medical AB
Lumito AB
Irras AB

Why is Acarix AB ?

1
With a growth in Net Sales of 13.22%, the company declared Very Positive results in Mar 26
  • The company has declared positive results for the last 7 consecutive quarters
  • OPERATING CASH FLOW(Y) Highest at SEK -24.49 MM
  • ROCE(HY) Highest at -88.29%
  • DEBTORS TURNOVER RATIO(HY) Highest at 1.62 times
2
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of -16.56%, its profits have risen by 27.4%
3
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -16.56% returns in the last 1 year, the stock has also underperformed OMX Stockholm 30 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to Acarix AB should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Acarix AB for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Acarix AB
-100.0%
-0.27
48.73%
OMX Stockholm 30
28.68%
1.89
15.95%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
27.67%
EBIT Growth (5y)
-3.40%
EBIT to Interest (avg)
-63.35
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.75
Sales to Capital Employed (avg)
0.13
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
8.83
EV to EBIT
-6.64
EV to EBITDA
-7.16
EV to Capital Employed
16.02
EV to Sales
43.30
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-241.30%
ROE (Latest)
-125.98%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
Bearish
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

21What is working for the Company
OPERATING CASH FLOW(Y)

Highest at SEK -24.49 MM

ROCE(HY)

Highest at -88.29%

DEBTORS TURNOVER RATIO(HY)

Highest at 1.62 times

RAW MATERIAL COST(Y)

Fallen by -86.01% (YoY

NET SALES(Q)

Highest at SEK 2.42 MM

OPERATING PROFIT(Q)

Highest at SEK -7.8 MM

OPERATING PROFIT MARGIN(Q)

Highest at -321.86 %

PRE-TAX PROFIT(Q)

Highest at SEK -8.78 MM

NET PROFIT(Q)

Highest at SEK -8.78 MM

EPS(Q)

Highest at SEK -0.01

0What is not working for the Company
NO KEY NEGATIVE TRIGGERS

Here's what is working for Acarix AB

Operating Cash Flow
Highest at SEK -24.49 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (SEK MM)

Debtors Turnover Ratio
Highest at 1.62 times and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Net Sales
Highest at SEK 2.42 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (SEK MM)

Net Sales
At SEK 2.42 MM has Grown at 31.74%
over average net sales of the previous four periods of SEK 1.84 MM
MOJO Watch
Near term sales trend is positive

Net Sales (SEK MM)

Operating Profit
Highest at SEK -7.8 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (SEK MM)

Operating Profit Margin
Highest at -321.86 %
in the last five periods
MOJO Watch
Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit
Highest at SEK -8.78 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (SEK MM)

Net Profit
Highest at SEK -8.78 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (SEK MM)

EPS
Highest at SEK -0.01
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (SEK)

Raw Material Cost
Fallen by -86.01% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales